Cerebrovascular Accident Clinical Trial
Official title:
Role of the Intact Hemisphere in Recovery of Motor Function After Stroke
The purpose of this study is to better understand the role of the motor part of the brain in
the recovery of motor function after stroke. The motor deficits that follow a stroke are
compensated for over several months. It has been proposed that the ipsilateral motor cortex
mediates these recovery processes. The results of this study will provide fundamental
information on the role of ipsilateral M1 in recovery of motor function after chronic
stroke.
A general patient evaluation will determine the location of the lesion site and assess the
degree of impairment in motor and global cognitive functioning. An assessment of motor
function will also be performed. Patients will be divided into two groups: well and poorly
recovered. An MRI (magnetic resonance imaging) scan may also be done if one has not been
performed in the past 6 months.
Two main procedures will be performed: transcranial magnetic stimulation (TMS) and test of
motor performance. In the first procedure, a metal coil surrounded by a plastic mold will be
placed on the head and electrical current will be pulsed through it. The electrical muscle
activity will be recorded through these electrodes with a computer. The second procedure
involves a reaction time test. The task will consist of reacting to a visual stimulus by
performing a voluntary movement. TMS pulses will be given before each movement. This is done
to determine whether this type of stimulation interferes with reaction time, which would
indicated that it interferes with the brain centers executing the reaction to the visual
Go-signal.
Patients with single ischemic hemispheric lesions at least 12 months after the stroke who
initially had a severe paralysis of the arm will be recruited for the study. Healthy normal
volunteers will also be included in the study. A special effort will be made to increase the
participation of women and diverse racial groups.
Status | Completed |
Enrollment | 80 |
Est. completion date | December 2004 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
INCLUSION CRITERIA: Patients with single ischemic hemispheric lesions at least 12 months after the stroke who had a severe paresis (below MRC grade 2) of the affected arm initially. An anatomical MRI scan will be acquired at the NIH if a recent one (within 6 months) is not available. Normal volunteers who are willing and able to perform the tasks will be included in the study. Healthy normal volunteers recruited for the study will receive neurological and physical exams to ensure their healthy conditions. EXCLUSION CRITERIA: Patients with more than one stroke. Patients with bilateral motor impairment. Patients with cerebellar or brainstem lesions. Patients or subjects unable to perform the task (wrist or elbow flexion at least MRC grade 2). Patients or subjects with history of severe alcohol or drug abuse, psychiatric illness like severe depression, poor motivational capacity, or severe language disturbances, particularly of receptive nature or with serious cognitive deficits (defined as equivalent to a mini-mental state exam score of 20 or less). Patients or subjects with severe uncontrolled medical problems (e.g. cardiovascular disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer or renal disease, any kind of end-stage pulmonary or cardiovascular disease, or a deteriorated condition due to age, uncontrolled epilepsy or others). Patients or subjects with metal in the cranium except mouth. Patients or subjects with dental braces, metal fragments from occupational exposure or surgical clips in or near the brain. Patients or subjects with eye, blood vessel, cochlear or eye implants. Patients or subjects with increased intracranial pressure as evaluated by clinical means. Patients with cardiac or neural pacemakers, intracardiac lines and/or implanted medication pumps. Patients or subjects with history of loss of consciousness or epilepsy. Patients or subjects with unstable cardiac dysrhythmia. Patients or subjects with h/o hyperthyroidism or individuals receiving drugs acting primarily on the central nervous system. |
N/A
Country | Name | City | State |
---|---|---|---|
United States | National Institute of Neurological Disorders and Stroke (NINDS) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Alagona G, Delvaux V, Gérard P, De Pasqua V, Pennisi G, Delwaide PJ, Nicoletti F, Maertens de Noordhout A. Ipsilateral motor responses to focal transcranial magnetic stimulation in healthy subjects and acute-stroke patients. Stroke. 2001 Jun;32(6):1304-9. — View Citation
Bridgers SL. The safety of transcranial magnetic stimulation reconsidered: evidence regarding cognitive and other cerebral effects. Electroencephalogr Clin Neurophysiol Suppl. 1991;43:170-9. Review. — View Citation
Cao Y, D'Olhaberriague L, Vikingstad EM, Levine SR, Welch KM. Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke. 1998 Jan;29(1):112-22. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05477238 -
Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls
|
N/A | |
Completed |
NCT00046293 -
ReoPro and Retavase to Treat Acute Stroke
|
Phase 2 | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Completed |
NCT01116544 -
Treatment of Chronic Stroke With AMES + EMG Biofeedback
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Active, not recruiting |
NCT02563886 -
Electrically Assisted Movement Therapy
|
N/A | |
Recruiting |
NCT02446730 -
Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
|
Phase 4 | |
Completed |
NCT02141932 -
Pocket-size Cardiovascular Ultrasound in Stroke
|
N/A | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Recruiting |
NCT01769326 -
Influence of Timing on Motor Learning
|
N/A | |
Recruiting |
NCT02557737 -
Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities
|
Phase 3 | |
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Completed |
NCT01423201 -
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
|
||
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT01656876 -
The Effects of Mirror Therapy on Upper Extremity in Stroke Patients
|
N/A | |
Withdrawn |
NCT00573092 -
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
|
N/A | |
Completed |
NCT00542256 -
tDCS and Physical Therapy in Stroke
|
N/A | |
Completed |
NCT00377689 -
Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke
|
Phase 2 | |
Recruiting |
NCT00166751 -
Sonographic Assessment of Laryngeal Elevation
|
N/A | |
Terminated |
NCT00120289 -
Niacin Plus Statin to Prevent Vascular Events
|
Phase 3 |